Vascular endothelial growth factor and fibroblast growth factor 5 are colocalized in vascular and avascular epiretinal membranes
- PMID: 9323936
- DOI: 10.1016/s0002-9394(14)70861-x
Vascular endothelial growth factor and fibroblast growth factor 5 are colocalized in vascular and avascular epiretinal membranes
Abstract
Purpose: To determine by immunocytochemical analysis of epiretinal membranes whether vascular endothelial growth factor and the fibroblast growth factor FGF-5 are present in patients with proliferative diabetic retinopathy or proliferative vitreoretinopathy.
Methods: Human surgical specimens of epiretinal membranes were obtained from 11 eyes with proliferative diabetic retinopathy and five eyes with proliferative vitreoretinopathy. Sections were immunostained with an affinity-purified antibody against an internal sequence of human FGF-5 and with a commercially available affinity-purified antibody corresponding to the first 20 residues of human vascular endothelial growth factor. Slides were visualized using avidin-biotin-peroxidase complex. Control studies were performed with nonimmune immunoglobulin G and preabsorbed vascular endothelial growth factor and FGF-5 antibody, respectively.
Results: Immunoreactive FGF-5 is present in most cells, including endothelial cells of vascular and avascular epiretinal membranes, but seems to be absent from the extracellular matrix. A similar staining pattern was observed for vascular endothelial growth factor.
Conclusions: Vascular endothelial growth factor and FGF-5 are remarkably colocalized in both vascular and avascular epiretinal membranes arising from proliferative diabetic retinopathy and proliferative vitreoretinopathy, respectively. This result questions the concept that the presence of a single angiogenic factor determines the vascular status of an epiretinal proliferation.
Similar articles
-
Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker.Ophthalmologica. 1998;212(6):410-4. doi: 10.1159/000027378. Ophthalmologica. 1998. PMID: 9787233
-
Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.Int J Clin Pract. 2005 Oct;59(10):1157-61. doi: 10.1111/j.1368-5031.2005.00573.x. Int J Clin Pract. 2005. PMID: 16178982
-
Alphab-crystallin expression in epiretinal membrane of human proliferative diabetic retinopathy.Retina. 2012 Jun;32(6):1190-6. doi: 10.1097/IAE.0b013e318233ab9c. Retina. 2012. PMID: 22371118
-
Co-Expression of Podoplanin and CD44 in Proliferative Vitreoretinopathy Epiretinal Membranes.Int J Mol Sci. 2023 Jun 4;24(11):9728. doi: 10.3390/ijms24119728. Int J Mol Sci. 2023. PMID: 37298679 Free PMC article. Review.
-
Mechanisms in proliferative vitreoretinopathy.Ophthalmol Clin North Am. 2002 Mar;15(1):81-6. doi: 10.1016/s0896-1549(01)00008-6. Ophthalmol Clin North Am. 2002. PMID: 12064085 Review.
Cited by
-
miRNA signatures in diabetic retinopathy and nephropathy: delineating underlying mechanisms.J Physiol Biochem. 2022 Feb;78(1):19-37. doi: 10.1007/s13105-021-00867-0. Epub 2022 Jan 31. J Physiol Biochem. 2022. PMID: 35098434 Review.
-
Reduced effect of anti-vascular endothelial growth factor agents on diabetics with vitreomacular interface abnormalities.Int Ophthalmol. 2014 Aug;34(4):817-23. doi: 10.1007/s10792-013-9884-6. Epub 2013 Nov 22. Int Ophthalmol. 2014. PMID: 24272276
-
Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers.Vasc Health Risk Manag. 2008;4(3):575-96. doi: 10.2147/vhrm.s1991. Vasc Health Risk Manag. 2008. PMID: 18827908 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical